UDI IMPLEMENTATION – The Key to Unlock Personalized Medicine?
FDA Report “Coordinated Registry Networks to Bridge Clinical Care and Research”
FDA Report “Coordinated Registry Networks to Bridge Clinical Care and Research”
This white paper “UDI: The Key to Unlock Personalized Medicine?” provides Life Sciences firms with the ability to see how the implementation of Unique Device Identification (UDI) is having a profound effect on Med-Tech manufacturers, healthcare providers, regulators and ultimately the patient.
President of Axendia Daniel R Matlis and Research Associate Ellyn McMullin explore how changes in regulations requiring a UDI on packaging of implantable, life-supporting and life-sustaining devices must bear a UDI and date.
In addition, FDA’s new report: “Coordinated Registry Networks to Bridge Clinical Care and Research” calls for the adoption of UDI in patient identification across the entire device life cycle.
Could UDI be a key that unlocks the potential of personalized medicine for the masses?
Complete the form to find out how.